Jiangsu Honghui Equity Investment Management
Overview
A private investment firm founded in 2014, dedicated to creating long-term value by promoting technology innovations. The firm specializes in the healthcare, biomedicine, medical technology, and consumer-related sectors, leveraging its expertise in chemical, biological, and material sciences to invest in companies that enhance manufacturing efficiency and human wellness. It operates globally with offices in Shanghai, Tokyo, Hong Kong, and Boston.
Portfolio Companies
3
Website
highlight-capital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beijing Geneplus Technology | Nov 2020 | Series B Extension | Co-investor |
| Inmagene | Jun 2021 | Series C | - |
| ABM Therapeutics | Jan 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Jiangsu Honghui Equity Investment Management based?
Jiangsu Honghui Equity Investment Management is headquartered in Shanghai, Shanghai, China.
When was Jiangsu Honghui Equity Investment Management founded?
Founding year information for Jiangsu Honghui Equity Investment Management is not publicly available.
How many portfolio companies does Jiangsu Honghui Equity Investment Management have?
Jiangsu Honghui Equity Investment Management has 3 portfolio companies in Caplight's dataset.
What are some companies in Jiangsu Honghui Equity Investment Management's portfolio?
Portfolio companies visible on Caplight include Beijing Geneplus Technology, Inmagene, ABM Therapeutics.
What was Jiangsu Honghui Equity Investment Management's most recent investment shown here?
Jiangsu Honghui Equity Investment Management's most recent investment in this portfolio sample was in ABM Therapeutics in 2022.
What sectors does Jiangsu Honghui Equity Investment Management focus on?
Jiangsu Honghui Equity Investment Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Jiangsu Honghui Equity Investment Management focus on?
Jiangsu Honghui Equity Investment Management typically invests at the Mid stage.
What is Jiangsu Honghui Equity Investment Management's AUM?
Jiangsu Honghui Equity Investment Management's assets under management are estimated between $2.6B and $3.8B.